Evidence map›Paper›PMID 25617763›Full record

ArticlePloS one2015

Hippocampal neuro-networks and dendritic spine perturbations in epileptogenesis are attenuated by neuroprotectin d1.

Alberto E Musto, Chelsey P Walker, Nicos A Petasis, Nicolas G Bazan

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Sex differences in the transition to chronic pain.The Journal of clinical investigation · 2025
    Review
  6. Article
  7. GABATranslational psychiatry · 2024
    Article
  8. Article
  9. Review
  10. The role of dendritic spines in epileptogenesis.Frontiers in cellular neuroscience · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. α4βδ GABANeuroscience · 2019
    Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Alberto E MustoNeuroscience Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
Chelsey P WalkerNeuroscience Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
Nicos A PetasisDepartment of Chemistry, Loker Hydrocarbon Research Institute, University of Southern California, Los Angeles, California, United States of America.
Nicolas G BazanNeuroscience Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
Louisiana State University Health Sciences Center New Orleans · USUniversity of Southern California · US

Funding

Multiphoton ConfocalP30GM103340 · NIGMS · LSU HEALTH SCIENCES CENTER · PI BAZAN, NICOLAS G. · 2012 to 2016
$5.1M
NIGMS NIH HHS P30 GM103340NIGMS NIH HHS P30-GM103340
6 · The paper itself

Abstract

purposeLimbic epileptogenesis triggers molecular and cellular events that foster the establishment of aberrant neuronal networks that, in turn, contribute to temporal lobe epilepsy (TLE). Here we have examined hippocampal neuronal network activities in the pilocarpine post-status epilepticus model of limbic epileptogenesis and asked whether or not the docosahexaenoic acid (DHA)-derived lipid mediator, neuroprotectin D1 (NPD1), modulates epileptogenesis.

methodsStatus epilepticus (SE) was induced by intraperitoneal administration of pilocarpine in adult male C57BL/6 mice. To evaluate simultaneous hippocampal neuronal networks, local field potentials were recorded from multi-microelectrode arrays (silicon probe) chronically implanted in the dorsal hippocampus. NPD1 (570 μg/kg) or vehicle was administered intraperitoneally daily for five consecutive days 24 hours after termination of SE. Seizures and epileptiform activity were analyzed in freely-moving control and treated mice during epileptogenesis and epileptic periods. Then hippocampal dendritic spines were evaluated using Golgi-staining.

resultsWe found brief spontaneous microepileptiform activity with high amplitudes in the CA1 pyramidal and stratum radiatum in epileptogenesis. These aberrant activities were attenuated following systemic NPD1 administration, with concomitant hippocampal dendritic spine protection. Moreover, NPD1 treatment led to a reduction in spontaneous recurrent seizures.

conclusionsOur results indicate that NPD1 displays neuroprotective bioactivity on the hippocampal neuronal network ensemble that mediates aberrant circuit activity during epileptogenesis. Insight into the molecular signaling mediated by neuroprotective bioactivity of NPD1 on neuronal network dysfunction may contribute to the development of anti-epileptogenic therapeutic strategies.

Indexed as

AnimalsDendritic SpinesDocosahexaenoic AcidsEpilepsy, Temporal LobeHippocampusLimbic SystemMaleMiceMice, Inbred C57BLNerve NetPilocarpineStatus EpilepticusDocosahexaenoic AcidsPilocarpineprotectin D1

Identifiers

PMID25617763
PMCPMC4305283
OpenAlexW2062037597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.